Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Joinn Laboratories (China) Co Days Payable?
Joinn Laboratories (China) CoSHSE:603127 +3.72%78 Days Payable is 23.10 as of Mar. 2026, which is 22% below its 10-year median of 29.69. GuruFocus rates SHSE:603127 with a GF Score™ of 78/100 and a GF Value™ of ¥17.43 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Joinn Laboratories (China) Co ranks worse than 92.11% on this metric.
The historical rank and industry rank for Joinn Laboratories (China) Co's Days Payable or its related term are showing as below:
SHSE:603127'
s Days Payable Range Over the Past 10 Years
Min: 11.82 Med: 29.69 Max: 45.33
Current: 14.98
During the past 13 years, Joinn Laboratories (China) Co's highest Days Payable was 45.33. The lowest was 11.82. And the median was 29.69.
SHSE:603127's Days Payable is ranked worse than 92.11% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.945
vs SHSE:603127: 14.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603127 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joinn Laboratories (China) Co Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Joinn Laboratories (China) Co's Days Payable falls into.
Joinn Laboratories (China) Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joinn Laboratories (China) Co (SHSE:603127) has a Days Payable of 23.10 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Joinn Laboratories (China) Co and its competitors. This is 22% below median its historical median of 29.69. Over the past decade, Joinn Laboratories (China) Co's Days Payable has ranged from 11.82 to 45.33. According to the industry distribution chart, Joinn Laboratories (China) Co ranks #175 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 92.1%.
Is Joinn Laboratories (China) Co's Days Payable too high?
Joinn Laboratories (China) Co's current Days Payable of 23.10 is 22% below median its 10-year median of 29.69. Over the past 10 years, this metric has ranged from a low of 11.82 to a high of 45.33. The Medical Diagnostics & Research industry median Days Payable is 64.95. Joinn Laboratories (China) Co's value of 23.10 is 64.4% below this industry median. Based on the distribution chart, Joinn Laboratories (China) Co ranks #175 out of 190 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Joinn Laboratories (China) Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Joinn Laboratories (China) Co's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Joinn Laboratories (China) Co ranks #175 out of 190 companies for Days Payable. This places Joinn Laboratories (China) Co in the lower half of its industry. The industry median Days Payable is 64.95. Joinn Laboratories (China) Co's value of 23.10 is 64.4% below this benchmark. Historically, Joinn Laboratories (China) Co's own Days Payable has ranged from 11.82 to 45.33 over the past decade. While the company's 10-year median is 29.69 vs. the industry median of 64.95, Joinn Laboratories (China) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.95, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joinn Laboratories (China) Co's current Days Payable of 23.10 is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Joinn Laboratories (China) Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joinn Laboratories (China) Co's current Days Payable is 23.10, which is 22% below median its own 10-year median of 29.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joinn Laboratories (China) Co stock overvalued right now?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co (SHSE:603127) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.43, compared to a current price of ¥41.54 — trading 138.3% above its estimated fair value. The current Days Payable is 23.10, which is 22% below median its 10-year median of 29.69 and 64.4% below the Medical Diagnostics & Research industry median of 64.95. Joinn Laboratories (China) Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Joinn Laboratories (China) Co (SHSE:603127), the current Days Payable is 23.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joinn Laboratories (China) Co (SHSE:603127) Overvalued in 2026?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co stock appears to be overvalued.
The current stock price of ¥41.54 is trading 138.3% above its estimated GF Value™ of ¥17.43.
GuruFocus considers Joinn Laboratories (China) Co to be Significantly Overvalued.
Key valuation signals for SHSE:603127:
Days Payable: 23.10 (22% below median its 10-year median of 29.69)
GF Value™: ¥17.43 vs. price of ¥41.54 (138.3% above fair value)
Industry Position: 64.4% below the Medical Diagnostics & Research median (#175 of 190)
No single metric tells the full story. See the SHSE:603127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
78GF Score
Get the complete analysis for SHSE:603127
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603127 has been successfully added to your 
